Sort
21,281 grants matching “influenza”
Structural biology and immunogen design
$1,137,348Stephen C Harrison · Boston Children'S Hospital · P01 · FY2019 · AI
Vaccine and Treatment Evaluation Units
$1,137,245Nadine Georges Rouphael · Emory University · UM1 · FY2024 · AI
Diagnostic and Prognostic Biomarkers for Viral Severe Lung Disease
$1,137,211Ralph S Baric · Columbia University Health Sciences · U19 · FY2015 · AI
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$1,136,944Scott Dexter Boyd · Stanford University · R01 · FY2018 · AI
Crossprotective CTL Against Influenza
$1,136,663Ellis L Reinherz · Dana-Farber Cancer Inst · U01 · FY2012 · AI
Crossprotective CTL Against Influenza
$1,136,663Ellis L Reinherz · Dana-Farber Cancer Inst · U01 · FY2014 · AI
Immunobiology of Influenza Virus-related Critical Illness in Young Hosts
$1,136,468Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2022 · AI
Structure-Guided Design of CD4 T cell Memory-Enhanced rHA H7N9 Influenza Vaccine
$1,136,044Anne Searls De Groot · Epivax, Inc. · R01 · FY2020 · AI
New Strategies to Prevent Death from Influenza
$1,135,759Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2007 · AI
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,135,695Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Differentiation of Common Respiratory Viruses and SARS
$1,135,645Idaho Technology · U01 · FY2005 · AI
DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES
$1,134,588Rustom Noshir Antia · Emory University · U01 · FY2024 · AI
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.
$1,133,980Mark M Davis · Stanford University · U19 · FY2020 · AI
Section on High Resolution Optical Imaging
$1,133,394Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2013 · EB
Universal room temperature stable influenza nanovaccine
$1,132,987Balaji Narasimhan · Iowa State University · R01 · FY2020 · AI
Diagnostic and Prognostic Biomarkers for Viral Severe Lung Disease
$1,131,261Ralph S Baric · Columbia University Health Sciences · U19 · FY2017 · AI
STRENGTHENING SURVEILLANCE & RESPONSE TO SEASONAL & PANDEMIC INFLUENZA
$1,131,000Jean-Baptiste Roungou · World Health Organization Regional Off · U51 · FY2011 · IP
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
$1,130,292Pandurangan Vijayanand · La Jolla Institute For Immunology · U01 · FY2023 · CA
Reducing Transmission of Influenza by Face Masks
$1,128,794Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2007 · CI
Skin Vaccination Against Influenza in the Young And Aged
$1,127,696Richard W Compans · Emory University · R01 · FY2018 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2025 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2023 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2024 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2021 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2022 · AI